Loo WT - Search Results

1

Outcomes of adjuvant endocrine therapy and hormone receptor status change following neoadjuvant chemotherapy in breast cancer patients.

Wu JY, Chen WG, Chen XS, Huang O, He JR, Zhu L, Li Y, Shen KW, Chow LW, Loo WT, Chow CY, Tsang W. Wu JY, et al. Among authors: loo wt. Int J Biol Markers. 2014 Dec 9;29(4):e380-6. doi: 10.5301/jbm.5000113. Int J Biol Markers. 2014. PMID: 25385240 Free article.

2

Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer.

Tang Y, Zhu L, Li Y, Ji J, Li J, Yuan F, Wang D, Chen W, Huang O, Chen X, Wu J, Shen K, Loo WT, Chow LW. Tang Y, et al. Among authors: loo wt. J Transl Med. 2012 Sep 19;10 Suppl 1(Suppl 1):S4. doi: 10.1186/1479-5876-10-S1-S4. Epub 2012 Sep 19. J Transl Med. 2012. PMID: 23046633 Free PMC article.

3

New developments in breast cancer prognosis: molecular predictors of treatment response and survival.

Foo EM, Boost MV, Wong AS, Loo WT, Chow LW, Chow CY. Foo EM, et al. Among authors: loo wt. Int J Biol Markers. 2013 Jun 28;28(2):131-40. doi: 10.5301/jbm.5000027. Int J Biol Markers. 2013. PMID: 23709349 Free article.

4

Current directions for COX-2 inhibition in breast cancer.

Chow LW, Loo WT, Toi M. Chow LW, et al. Among authors: loo wt. Biomed Pharmacother. 2005 Oct;59 Suppl 2:S281-4. doi: 10.1016/s0753-3322(05)80046-0. Biomed Pharmacother. 2005. PMID: 16507393 Review.

5

The future perspectives of breast cancer therapy.

Chow LW, Yiu CC, Yip AY, Loo WT. Chow LW, et al. Among authors: loo wt. Biomed Pharmacother. 2006 Jul;60(6):259-62. doi: 10.1016/j.biopha.2006.06.010. Epub 2006 Jun 23. Biomed Pharmacother. 2006. PMID: 16824726 Review.

6

Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients.

Chow LWC, Biganzoli L, Leo AD, Kuroi K, Han HS, Patel J, Huang CS, Lu YS, Zhu L, Chow CYC, Loo WTY, Glück S, Toi M. Chow LWC, et al. Asia Pac J Clin Oncol. 2017 Dec;13(6):372-378. doi: 10.1111/ajco.12682. Epub 2017 Mar 28. Asia Pac J Clin Oncol. 2017. PMID: 28371190

7

Possible predictive markers related to micro-metastasis in breast cancer patients.

Zhu L, Loo WT, Cheng CW, Chow LW. Zhu L, et al. Among authors: loo wt. Oncol Rep. 2006 May;15(5):1217-23. Oncol Rep. 2006. PMID: 16596190

8

Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response.

Lau GI, Loo WT, Chow LW. Lau GI, et al. Among authors: loo wt. Biomed Pharmacother. 2007 Oct;61(9):562-5. doi: 10.1016/j.biopha.2007.08.013. Epub 2007 Sep 17. Biomed Pharmacother. 2007. PMID: 17913448

9

Factors predicting seroma formation after mastectomy for Chinese breast cancer patients.

Loo WT, Chow LW. Loo WT, et al. Indian J Cancer. 2007 Jul-Sep;44(3):99-103. doi: 10.4103/0019-509x.38940. Indian J Cancer. 2007. PMID: 18250530 Free article.

10

Presence of extensive intraductal component in patients undergoing breast conservative surgery predicts presence of residual disease in subsequent completion mastectomy.

Yiu CC, Loo WT, Lam CK, Chow LW. Yiu CC, et al. Among authors: loo wt. Chin Med J (Engl). 2009 Apr 20;122(8):900-5. Chin Med J (Engl). 2009. PMID: 19493411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters